key: cord-0787677-yvv0rh5l authors: Berlingieri, Giuseppina; Alvares, Cristina Maria Arvate; Serrano, Rafael Verardi; Palma, Luiz Felipe; Campos, Luana title: Phototherapies for COVID-19-associated opportunistic oral infections date: 2021-12-08 journal: Photodiagnosis Photodyn Ther DOI: 10.1016/j.pdpdt.2021.102678 sha: 6aee7037363354badc2fbb0d7349bb34e3d29c03 doc_id: 787677 cord_uid: yvv0rh5l Opportunistic infections are widely described in patients with novel coronavirus disease 2019 (COVID-19); however, very few studies have addressed those affecting the oral cavity. Given the lack of information on the clinical presentations and the available treatment options, the present study aimed to show a case in which a combination of antimicrobial photodynamic therapy (aPDT) and photobiomodulation therapy (PBMT) was used for the management of two concomitant COVID-19-associated opportunistic oral infections (oral pseudomembranous candidiasis and recurrent herpes labialis). Within 7 days and without any systemic drug administration, all the lesions resolved completely, and the patient no longer reported oral pain or discomfort. According to the current case report and taking into consideration the significant gaps in the knowledge and understanding of COVID-19, this combination of phototherapy modalities seems to be a promising tool for managing viral and fungal opportunistic oral infections. • A simple, non-invasive protocol based on aPDT and PBMT. • Improvement of oral lesions within a few days. Opportunistic infections are widely described in patients with novel coronavirus disease 2019 (COVID-19); however, very few studies have addressed those affecting the oral cavity. Given the lack of information on the clinical presentations and the available treatment options, the present study aimed to show a case in which a combination of antimicrobial photodynamic therapy (aPDT) and photobiomodulation therapy (PBMT) was used for the management of two concomitant COVID-19-associated opportunistic oral infections (oral pseudomembranous candidiasis and recurrent herpes labialis). Within 7 days and without any systemic drug administration, all the lesions resolved completely, and the patient no longer reported oral pain or discomfort. According to the current case report and taking into consideration the significant gaps in the knowledge and understanding of COVID-19, this combination of phototherapy modalities seems to be a promising tool for managing viral and fungal opportunistic oral infections. Keywords: COVID-19, SARS-CoV-2, Antimicrobial photodynamic therapy, Photobiomodulation therapy, Herpes Labialis, Candidiasis. The high incidence rates of severe infection and mortality of the Novel Coronavirus disease 2019 (COVID-19) are probably related to inefficient immunity to the virus, viral replication in the respiratory tract, and coinfections [1] . There is not enough information on COVID-19-associated opportunistic infections to date; however, the most common in critical patients are those affecting the respiratory tract, bloodstream, and urinary tract [2] . Moreover, fungal infections are the most frequently reported, followed by viral, bacterial, protozoa, and helminth ones [3] . Orofacial lesions have already been described in COVID-19 patients [4] . Some hypothesize that these lesions would arise from indirect mechanisms of viral infection, i.e., from either the compromised general medical status or therapeutic drugs administered [5] . Within the group of COVID-19-associated opportunistic oral infections, despite limited studies, the most reported so far include candidiasis and herpes simplex infection [6] . In light of these facts, this article reports a clinical case in which a combination of antimicrobial photodynamic therapy (aPDT) and photobiomodulation therapy (PBMT) was used for the management of COVID-19-associated opportunistic oral infections. A Brazilian 88-year-old female, with no history of chronic diseases, sought medical help owing to a flu-like syndrome suggestive of COVID-19. The RT-PCR test confirmed the clinical suspicion and azithromycin and prednisone were prescribed. About 10 days later, he developed pneumonia, dyspnea, and a painful, burning sensation throughout her mouth. Levofloxacin, dexamethasone, acetylsalicylic acid, and acetylcysteine were prescribed, as well as ipratropium bromide inhalation. After a mild improvement in the clinical medical status, the patient attended a private dental office complaining of oral pain arising from the upper denture. It was noted two bleeding ulcers on the lower lip and extensive, creamy white, plaque-like lesions throughout the oral cavity, which could be removed by gentle scraping, leaving the underlying mucosal surface erythematous. According to the clinical signs, symptoms, and the past medical history, diagnoses of oral pseudomembranous candidiasis and recurrent herpes labialis were given. At the first appointment, an aPDT session was suggested ( Figure 1A On the seventh day, all the lesions resolved completely ( Figure 1E ,F). The patient reported total pain remission and no difficulty in eating, drinking, and speaking. The combination of phototherapies resulted in an important clinical improvement of the patient's oral condition within a few days. To the best of the authors' knowledge, this is the first report case on the benefits of this phototherapeutic approach to two concomitant COVID-19-associated opportunistic oral infections (i.e., fungal and viral infections). Immunosuppressive therapy is considered an important risk factor for opportunistic infections in COVID-19 patients. Corticosteroids are immunosuppressive drugs commonly prescribed for these patients [3] , as seen in the current case report. Besides that, the patient also received long-term antibiotics, which probably altered her oral microbiota. Given the effectiveness of aPDT in inhibiting bacterial, fungal, and viral infections, as well as the potential of PBMT for pain relief and inflammation control [5] , the authors hypothesized that combining both phototherapies would be interesting. Moreover, taking into account that drug-drug interaction may be a challenge in opportunistic infections in COVID-19 patients [3] , no systemic medication was needed for the resolution of the local coinfections. Other advantages comprised ease of application, low cost, and safety [4] . Despite the positive clinical result achieved within a short period, the current study has clear limitations as every case report. Given that the first outbreak of COVID-19 has occurred very recently and well-controlled clinical investigations are still virtually impossible [5] , case reports might provide clinicians early information and novel insights into the treatment and pathophysiology of emerging diseases and conditions such as COVID-19 [4] . Therefore, further studies are actually required to better elucidate the role of these phototherapies in COVID-19-associated opportunistic oral infections. Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity? Risks and features of secondary infections in severe and critical ill COVID-19 patients COVID-19-associated opportunistic infections: a snapshot on the current reports Photobiomodulation therapy and antimicrobial photodynamic therapy for orofacial lesions in patients with COVID-19: A case series A combination of phototherapy modalities for extensive lip lesions in a patient with SARS-CoV-2 infection Oral Manifestations of COVID-19: Updated Systematic Review With Meta-Analysis FIGURE LEGENDS Figure 1. Clinical appearance: oral pseudomembranous candidiasis and recurrent herpes labialis lesions At diagnosis; C,D. 72 hours after the first laser session; E,F. 7 days after the first laser session